MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/15569527.2017.1382503

Медицинская библиотека · Cutaneous and ocular toxicology · 2017

Treatment of lichen planopilaris: methotrexate or cyclosporine a therapy?

Bulbul Baskan Emel, Yazici Serkan

Сравнительное исследованиеСтатьяПеревод в очереди

Аннотация

BACKGROUND

Because of irreversible outcome of the lichen planopilaris (LPP), systemic therapy should be used in early inflammatory stages of the disease, without allowing the irreversible scar formation and permanent hair loss.

OBJECTIVE

We assessed the efficacy and safety of methotrexate (MTX) and cyclosporine A (CsA) in the management of recalcitrant, extensive LPP and compared their efficacy and safety profile.

METHODS

We retrospectively analysed the 16 LPP cases treated with either CsA or MTX therapy. Clinical improvement was defined as the absence of reported symptoms, lack of progression and reduction in erythema and follicular hyperkeratosis found in SIAscopic images.

RESULTS

A total of 16 patients received either CsA (six cases) or MTX (10 cases) therapy. The dosage of CsA was between 3 and 5 mg/kg/day. The initial dosage of MTX was 10-15 mg/wk and tapered gradually. The clinical improvement was demonstrated significantly at SIAscopic images taken at the third months of therapy.

CONCLUSIONS

Our observations suggest that both MTX and CsA therapies provide similar clinical efficacy at the end of first month of therapy with dosages used in psoriasis therapy. MTX was found to be better tolerated in this study.

Для цитирования: Bulbul Baskan Emel, Yazici Serkan. Treatment of lichen planopilaris: methotrexate or cyclosporine a therapy?. Cutaneous and ocular toxicology. 2017. DOI: 10.1080/15569527.2017.1382503.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.